Dofetilide as activator of Na/Ca exchange: New perspectives on an 'old' drug : Eorial to: Dof"etilide enhances the contractility of rat ventricular myocytes via augmentation of Na+-Ca2+ exchange by" Xuan-Ping Zhang et al.

Cardiovascular Drugs and Therapy

Volumn 23, Issue 3, 2009, Pages 189-192

  Antoons, Gudrun ^a,b   Sipido, Karin R ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Arrhythmias; Cardiac myocyte; Dofetilide; Heart failure; Na Ca exchange

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; DOFETILIDE;

EDITORIAL; HEART MUSCLE CONTRACTILITY; HUMAN; INOTROPISM; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SODIUM CALCIUM EXCHANGE;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM SIGNALING; MALE; MEMBRANE POTENTIALS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHENETHYLAMINES; RATS; RATS, WISTAR; SODIUM-CALCIUM EXCHANGER; SULFONAMIDES; VENTRICULAR FUNCTION, LEFT;

EID: 67649135871     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-009-6170-y     Document Type: Editorial

References (29)

1. 2+ exchange. Cardiovasc Drugs Ther. 2009;23. This issue.
2. M Gwilt JE Arrowsmith KJ Blackburn 1991 UK-68, 798-A novel, potent and highly selective Class-iii antiarrhythmic agent which blocks potassium channels in cardiac cells J Pharmacol Exp Ther 256 318 24
3. J Kiehn P Villena T Beyer 1994 Differential effects of the new Class-III agent dofetilide on potassium currents in guinea-pig cardiomyocytes J Cardiovasc Pharmacol 24 566 72
4. + current in cardiac myocytes by dofetilide J Pharmacol Exp Ther 262 809 17
5. AJ Camm I Savelieva 2008 New antiarrhythmic drugs for atrial fibrillation: Focus on dronedarone and vernakalant J Interv Card Electrophysiol 23 7 14
6. F Lombardi P Terranova 2006 Pharmacological treatment of atrial fibrillation: Mechanisms of action and efficacy of class III drugs Curr Med Chem 13 1635 53
7. GS Kamath S Mittal 2008 The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death Prog Cardiovasc Dis 50 439 48
8. C Torp-Pedersen M Moller PE Bloch-Thomsen 1999 Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 857 65
9. OD Pedersen H Bagger N Keller 2001 Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function-A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy Circulation 104 292 6
10. S Srivastava L Collis A Go 2005 Paradoxical effect of dofetilide on action potential duration and calcium transient amplitude in newborn rabbit ventricular myocytes J Cardiovasc Pharmacol 45 165 74
11. PM Tande H Bjornstad T Yang 1990 Rate-dependent Class-III antiarrhythmic action, negative chronotropy, and positive inotropy of A Novel Ik Blocking Drug, Uk-68, 798-Potent in Guinea-pig but no effect in rat myocardium J Cardiovasc Pharmacol 16 401 10
12. E Mortensen PM Tande NE Klow 1990 Positive inotropy linked with Class-III antiarrhythmic action-electrophysiological effects of the cardiotonic agent DPI 201-106 in the dog heart in vivo Cardiovasc Res 24 911 7
13. 2+ transient of failing human ventricular myocytes Circ Res 84 435 44
14. 2+ release in hypertrophied cardiac myocytes from dogs with chronic atrioventricular block J Physiol 579 147 60
15. MJ Shattock 1989 Bers DM. Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes Am J Physiol 256 C813 22
16. + transport mechanisms in cardiac hypertrophy and failure J Mol Cell Cardiol 35 5 25 (Pubitemid 36286964)
17. H Tanaka K Nishimaru T Aikawa 2002 Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents Br J Pharmacol 135 1096 100
18. CR Weber V Piacentino KS Ginsburg 2002 Na(+)-Ca(2+) exchange current and submembrane [Ca(2+)] during the cardiac action potential Circ Res 90 182 9
19. DA Eisner AW Trafford ME Diaz 1998 The control of Ca release from the cardiac sarcoplasmic reticulum: regulation versus autoregulation Cardiovasc Res 38 589 604 (Pubitemid 28319869)
20. 2+ exchanger Circ Res 87 581 7
21. 2+ exchange activity in canine pacing-induced heart failure Circ Res 87 690 8
22. 2+-exchanger protein levels and diastolic function of failing human myocardium Circulation 99 641 8
23. 2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: a potential link between contractile adaptation and arrhythmogenesis Circulation 102 2137 44
24. SM Pogwizd K Schlotthauer L Li 2001 Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual ß-adrenergic responsiveness Circ Res 88 1159 67
25. 2+ exchange blockers in the treatment of cardiac disease Expert Opin Investig Drugs 13 653 64
26. G Antoons KR Sipido 2008 Targeting calcium handling in arrhythmias Europace 10 1364 9
27. S Ozdemir V Bito P Holemans 2008 Pharmacological inhibition of Na/Ca exchange results in increased cellular Ca2 + load attributable to the predominance of forward mode block Circ Res 102 1398 405
28. L Formisano M Saggese A Secondo 2008 The two Isoforms of the Na+/Ca2 + exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway Mol Pharmacol 73 727 37
29. P Molinaro O Cuomo G Pignataro 2008 Targeted disruption of Na+/Ca2 + exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage J Neurosci 28 1179 84